Follow the people · Insider
Mark Van Oene
Mark Van Oene files insider transactions with the SEC as an officer of Pacific Biosciences Of California (PACB). We hold 4 disclosed purchases and sales filed since 24 May 2017, 1 of them in the last 90 days.
- Files forPACB
- Disclosed buys and sells4 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 January 2021 — 17 August 2026Officer · Pacific Biosciences Of California (PACB)34 Form 4 lines · source: SEC Form 4
- Filed 22 May 2017 — 5 November 2020SVP Chief Commercial Officer · Illumina (ILMN)73 Form 4 lines · source: SEC Form 4
Everything they disclosed
107 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 26,911 shares of Pacific Biosciences Of CaliforniaSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- was granted 489,130 shares of Pacific Biosciences Of CaliforniaSEC Form 411 August 2026Common Stock · traded 10 August 2026 · filed 11 August 2026
- was granted 1,967,888 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 411 August 2026Stock Option (right to buy) · traded 10 August 2026 · filed 11 August 2026
- ▼ sold on the open market 6,504 shares of Pacific Biosciences Of CaliforniaSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 6,504 shares of Pacific Biosciences Of CaliforniaSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- was granted 500,000 shares of Pacific Biosciences Of CaliforniaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- was granted 1,000,000 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 1,000,000 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 43 March 2026Stock Option (right to buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 500,000 shares of Pacific Biosciences Of CaliforniaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 129,790 shares of Pacific Biosciences Of CaliforniaSEC Form 419 February 2026Common Stock · traded 17 February 2026 · filed 19 February 2026
- ▼ sold on the open market 55,107 shares of Pacific Biosciences Of CaliforniaSEC Form 419 February 2026Common Stock · traded 18 February 2026 · filed 19 February 2026
- ▼ sold on the open market 129,790 shares of Pacific Biosciences Of CaliforniaSEC Form 419 February 2026Common Stock · traded 17 February 2026 · filed 19 February 2026
- ▼ sold on the open market 55,107 shares of Pacific Biosciences Of CaliforniaSEC Form 419 February 2026Common Stock · traded 18 February 2026 · filed 19 February 2026
- ▼ sold on the open market 26,836 shares of Pacific Biosciences Of CaliforniaSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- was granted 898,352 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 421 March 2025Stock Option (right to buy) · traded 19 March 2025 · filed 21 March 2025
- was granted 449,176 shares of Pacific Biosciences Of CaliforniaSEC Form 421 March 2025Common Stock · traded 19 March 2025 · filed 21 March 2025
- ▼ sold on the open market 6,486 shares of Pacific Biosciences Of CaliforniaSEC Form 45 March 2025Common Stock · traded 3 March 2025 · filed 5 March 2025
- ▼ sold on the open market 100,773 shares of Pacific Biosciences Of CaliforniaSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- ▼ sold on the open market 34,405 shares of Pacific Biosciences Of CaliforniaSEC Form 410 January 2025Common Stock · traded 10 January 2025 · filed 10 January 2025
- ▼ sold on the open market 38,011 shares of Pacific Biosciences Of CaliforniaSEC Form 420 August 2024Common Stock · traded 16 August 2024 · filed 20 August 2024
- ▼ sold on the open market 9,186 shares of Pacific Biosciences Of CaliforniaSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- was granted 798,076 shares of Pacific Biosciences Of CaliforniaSEC Form 426 February 2024Common Stock · traded 22 February 2024 · filed 26 February 2024
- ▼ sold on the open market 33,560 shares of Pacific Biosciences Of CaliforniaSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- ▼ sold on the open market 31,012 shares of Pacific Biosciences Of CaliforniaSEC Form 410 January 2024Common Stock · traded 9 January 2024 · filed 10 January 2024
- ▼ sold on the open market 26,102 shares of Pacific Biosciences Of CaliforniaSEC Form 418 August 2023Common Stock · traded 16 August 2023 · filed 18 August 2023
- was granted 328,500 shares of Pacific Biosciences Of CaliforniaSEC Form 46 March 2023Common Stock · traded 2 March 2023 · filed 6 March 2023
- ▼ sold on the open market 6,268 shares of Pacific Biosciences Of CaliforniaSEC Form 46 March 2023Common Stock · traded 3 March 2023 · filed 6 March 2023
- ▼ sold on the open market 26,722 shares of Pacific Biosciences Of CaliforniaSEC Form 411 January 2023Common Stock · traded 10 January 2023 · filed 11 January 2023
- was granted 300,000 shares of Pacific Biosciences Of CaliforniaSEC Form 426 August 2022Common Stock · traded 25 August 2022 · filed 26 August 2022
- was granted 433,200 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 44 March 2022Stock Option (right to buy) · traded 2 March 2022 · filed 4 March 2022
- was granted 72,500 shares of Pacific Biosciences Of CaliforniaSEC Form 44 March 2022Common Stock · traded 2 March 2022 · filed 4 March 2022
- ▼ sold on the open market 41,480 shares of Pacific Biosciences Of CaliforniaSEC Form 413 January 2022Common Stock · traded 11 January 2022 · filed 13 January 2022
- was granted 335,000 shares of Pacific Biosciences Of CaliforniaSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- was granted 750,000 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 412 January 2021Stock Option (right to buy) · traded 8 January 2021 · filed 12 January 2021
- had shares withheld for tax on 1,073 shares of IlluminaSEC Form 49 November 2020Common Stock · traded 5 November 2020 · filed 9 November 2020
- ▼ sold on the open market 585 shares of IlluminaSEC Form 42 September 2020Common Stock · traded 1 September 2020 · filed 2 September 2020
- ▼ sold on the open market 40 shares of IlluminaSEC Form 42 September 2020Common Stock · traded 1 September 2020 · filed 2 September 2020
- ▼ sold on the open market 625 shares of IlluminaSEC Form 45 August 2020Common Stock · traded 3 August 2020 · filed 5 August 2020
- ▼ sold on the open market 125 shares of IlluminaSEC Form 46 July 2020Common Stock · traded 1 July 2020 · filed 6 July 2020
- ▼ sold on the open market 100 shares of IlluminaSEC Form 46 July 2020Common Stock · traded 1 July 2020 · filed 6 July 2020
- ▼ sold on the open market 400 shares of IlluminaSEC Form 46 July 2020Common Stock · traded 1 July 2020 · filed 6 July 2020
- ▼ sold on the open market 525 shares of IlluminaSEC Form 43 June 2020Common Stock · traded 1 June 2020 · filed 3 June 2020
- ▼ sold on the open market 100 shares of IlluminaSEC Form 43 June 2020Common Stock · traded 1 June 2020 · filed 3 June 2020
- ▼ sold on the open market 525 shares of IlluminaSEC Form 45 May 2020Common Stock · traded 1 May 2020 · filed 5 May 2020
- ▼ sold on the open market 100 shares of IlluminaSEC Form 45 May 2020Common Stock · traded 1 May 2020 · filed 5 May 2020
- ▼ sold on the open market 1,250 shares of IlluminaSEC Form 420 April 2020Common Stock · traded 16 April 2020 · filed 20 April 2020
- exercised options over 8,210 shares of Illumina (a derivative holding)SEC Form 413 February 2020Performance Shares · traded 11 February 2020 · filed 13 February 2020
- exercised options over 3,431 shares of Illumina (a derivative holding)SEC Form 413 February 2020Performance Shares · traded 11 February 2020 · filed 13 February 2020
- was granted 4,105 shares of IlluminaSEC Form 413 February 2020Common Stock · traded 11 February 2020 · filed 13 February 2020
- exercised options over 8,210 shares of IlluminaSEC Form 413 February 2020Common Stock · traded 11 February 2020 · filed 13 February 2020
- was granted 1,716 shares of IlluminaSEC Form 413 February 2020Common Stock · traded 11 February 2020 · filed 13 February 2020
- exercised options over 3,431 shares of IlluminaSEC Form 413 February 2020Common Stock · traded 11 February 2020 · filed 13 February 2020
- had shares withheld for tax on 5,609 shares of IlluminaSEC Form 413 February 2020Common Stock · traded 11 February 2020 · filed 13 February 2020
- had shares withheld for tax on 2,552 shares of IlluminaSEC Form 413 February 2020Common Stock · traded 11 February 2020 · filed 13 February 2020
- was granted 6,243 shares of Illumina (a derivative holding)SEC Form 47 February 2020Performance Shares · traded 5 February 2020 · filed 7 February 2020
- was granted 2,081 shares of IlluminaSEC Form 47 February 2020Common Stock · traded 5 February 2020 · filed 7 February 2020
- ▼ sold on the open market 625 shares of IlluminaSEC Form 46 February 2020Common Stock · traded 5 February 2020 · filed 6 February 2020
- ▼ sold on the open market 225 shares of IlluminaSEC Form 46 January 2020Common Stock · traded 2 January 2020 · filed 6 January 2020
- ▼ sold on the open market 400 shares of IlluminaSEC Form 46 January 2020Common Stock · traded 2 January 2020 · filed 6 January 2020
- ▼ sold on the open market 625 shares of IlluminaSEC Form 44 December 2019Common Stock · traded 2 December 2019 · filed 4 December 2019
- had shares withheld for tax on 1,156 shares of IlluminaSEC Form 47 November 2019Common Stock · traded 5 November 2019 · filed 7 November 2019
- ▼ sold on the open market 625 shares of IlluminaSEC Form 45 November 2019Common Stock · traded 1 November 2019 · filed 5 November 2019
- ▼ sold on the open market 625 shares of IlluminaSEC Form 43 October 2019Common Stock · traded 1 October 2019 · filed 3 October 2019
- exercised options over 2,887 shares of Illumina (a derivative holding)SEC Form 414 February 2019Performance Shares · traded 12 February 2019 · filed 14 February 2019
- exercised options over 2,752 shares of Illumina (a derivative holding)SEC Form 414 February 2019Performance Shares · traded 12 February 2019 · filed 14 February 2019
- exercised options over 2,887 shares of IlluminaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- was granted 607 shares of IlluminaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- had shares withheld for tax on 1,719 shares of IlluminaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- exercised options over 2,752 shares of IlluminaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- was granted 578 shares of IlluminaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- had shares withheld for tax on 1,163 shares of IlluminaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- was granted 5,131 shares of Illumina (a derivative holding)SEC Form 413 December 2018Performance Shares · traded 11 December 2018 · filed 13 December 2018
- was granted 1,711 shares of IlluminaSEC Form 413 December 2018Common Stock · traded 11 December 2018 · filed 13 December 2018
- exercised options over 6,000 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 1,000 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 1,500 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 1,400 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 1,100 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 1,000 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 300 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 100 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 435 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- had shares withheld for tax on 1,218 shares of IlluminaSEC Form 47 November 2018Common Stock · traded 5 November 2018 · filed 7 November 2018
- exercised options over 6,000 shares of Illumina (a derivative holding)SEC Form 47 November 2018Non-qualified Stock Option (Right to Buy) · traded 5 November 2018 · filed 7 November 2018
- ▼ sold on the open market 1,091 shares of IlluminaSEC Form 46 September 2018Common Stock · traded 4 September 2018 · filed 6 September 2018
- ▼ sold on the open market 1,400 shares of IlluminaSEC Form 413 April 2018Common Stock · traded 12 April 2018 · filed 13 April 2018
- exercised options over 2,124 shares of Illumina (a derivative holding)SEC Form 420 February 2018Performance Shares · traded 15 February 2018 · filed 20 February 2018
- exercised options over 2,124 shares of IlluminaSEC Form 420 February 2018Common Stock · traded 15 February 2018 · filed 20 February 2018
- had shares withheld for tax on 735 shares of IlluminaSEC Form 420 February 2018Common Stock · traded 15 February 2018 · filed 20 February 2018
- ▼ sold on the open market 1,408 shares of IlluminaSEC Form 420 February 2018Common Stock · traded 16 February 2018 · filed 20 February 2018
- had shares withheld for tax on 294 shares of IlluminaSEC Form 430 January 2018Common Stock · traded 29 January 2018 · filed 30 January 2018
- was granted 2,102 shares of IlluminaSEC Form 413 December 2017Common Stock · traded 11 December 2017 · filed 13 December 2017
- was granted 6,306 shares of Illumina (a derivative holding)SEC Form 413 December 2017Performance Shares · traded 11 December 2017 · filed 13 December 2017
- ▼ sold on the open market 1,232 shares of IlluminaSEC Form 415 November 2017Common Stock · traded 13 November 2017 · filed 15 November 2017
- ▼ sold on the open market 18 shares of IlluminaSEC Form 415 November 2017Common Stock · traded 15 November 2017 · filed 15 November 2017
- had shares withheld for tax on 1,006 shares of IlluminaSEC Form 47 November 2017Common Stock · traded 6 November 2017 · filed 7 November 2017
- ▼ sold on the open market 1,250 shares of IlluminaSEC Form 413 October 2017Common Stock · traded 12 October 2017 · filed 13 October 2017
- exercised options over 5,838 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 1,800 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 3,154 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 884 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 2,200 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 626 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 300 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 765 shares of IlluminaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- exercised options over 5,838 shares of Illumina (a derivative holding)SEC Form 414 September 2017Non-qualified Stock Option (Right to Buy) · traded 12 September 2017 · filed 14 September 2017
- was granted 3,431 shares of Illumina (a derivative holding)SEC Form 424 May 2017Performance Shares · traded 22 May 2017 · filed 24 May 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.